Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 GM117321, R01 GM144608, R01 AI162911)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Bill and Melinda Gates Foundation
Article History
Received: 13 November 2023
Accepted: 27 February 2024
First Online: 23 March 2024
Competing interests
: E.B. has equity interests in Agragene Inc. and Synbal Inc., companies that may potentially benefit from the research results. E.B. also serves on the company’s Board of Directors (Synbal) and Scientific Advisory Board (Synbal and Agragene). The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. All other authors declare no competing interests.